Differential inhibition of prostacyclin production and platelet aggregation by aspirin.
D000293:Adolescent; D000328:Adult; D001241:Aspirin / Q000494:pharmacology*; D001792:Blood Platelets / Q000201:enzymology / Q000378:metabolism; D001808:Blood Vessels / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D011464:Epoprostenol / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D008297:Male; D008315:Malondialdehyde / Q000096:biosynthesis; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000096:biosynthesis*
D016861:Cyclooxygenase Inhibitors; D011453:Prostaglandins; D008315:Malondialdehyde; D011464:Epoprostenol; D001241:Aspirin